References
celiac disease
CELIAC DISEASE, TYPE 2 DIABETES MELLITUS
CONSORT 2010 participants flow diagram.Inclusion and exclusion criteria to the study.Sex: womenAge ≥ 18 years oldBMI ≥ 25 kg/mStable body weight during the last three months (±3 kg)History of chronic diseases (e.g., celiac disease, type 2 diabetes mellitus, and hepatic and pancreatic)Pregnant and breastfeeding womenSubjects who previously took CLA supplementation or dietary supplements which interfered with fat digestion or absorptionBMI—body mass index; CLA—conjugated linoleic acid.Content of fatty acids in capsules containing placebo and CLA.CLA—conjugated linoleic acid.Anthropometric characteristics of the study population.BMI—body mass index; CLA—conjugated linoleic acid; IQR—interquartile range.Comparison of densitometric parameters between CLA and placebo groups before the intervention.BMC—bone mineral content; BMD—bone mineral density; CLA—conjugated linoleic acid; IQR—interquartile range; SD—standard deviation; Comparison of differences in densitometric parameters between CLA and placebo groups.BMC—bone mineral content; BMD—bone mineral density; CLA—conjugated linoleic acid; IQR—interquartile range; SD—standard deviation.